Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
217 | 46988 | 32.0 | 74% |
Classes in level above (level 4) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
9 | 1091488 | GASTROENTEROLOGY & HEPATOLOGY//RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING//UROLOGY & NEPHROLOGY |
Classes in level below (level 2) |
ID, lev. below |
Publications | Label for level below |
---|---|---|
382 | 16384 | LUNG CANCER//THORAC SURG//TRANSBRONCHIAL NEEDLE ASPIRATION |
823 | 11253 | NON SMALL CELL LUNG CANCER//XRCC1//GEFITINIB |
1714 | 6107 | CIRCULATING TUMOR CELLS//DISSEMINATED TUMOR CELLS//UTEROGLOBIN |
1835 | 5652 | SMALL CELL LUNG CANCER//BOMBESIN//GASTRIN RELEASING PEPTIDE |
2018 | 4966 | BRAIN METASTASES//WHOLE BRAIN RADIOTHERAPY//NEOPLASTIC MENINGITIS |
2769 | 2626 | ISOLATED LUNG PERFUSION//PULMONARY TUMOR THROMBOTIC MICROANGIOPATHY//PULMONARY ALVEOLAR MICROLITHIASIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NON SMALL CELL LUNG CANCER | Author keyword | 1800 | 41% | 7% | 3404 |
2 | BRAIN METASTASES | Author keyword | 1689 | 65% | 3% | 1597 |
3 | LUNG CANCER | Author keyword | 1186 | 24% | 9% | 4284 |
4 | THORAC SURG | Address | 748 | 20% | 7% | 3319 |
5 | JOURNAL OF THORACIC ONCOLOGY | Journal | 734 | 48% | 2% | 1124 |
6 | CIRCULATING TUMOR CELLS | Author keyword | 537 | 67% | 1% | 488 |
7 | SMALL CELL LUNG CANCER | Author keyword | 536 | 46% | 2% | 882 |
8 | GEFITINIB | Author keyword | 534 | 52% | 2% | 735 |
9 | XRCC1 | Author keyword | 468 | 76% | 1% | 324 |
10 | ERLOTINIB | Author keyword | 411 | 48% | 1% | 630 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NON SMALL CELL LUNG CANCER | 1800 | 41% | 7% | 3404 | Search NON+SMALL+CELL+LUNG+CANCER | Search NON+SMALL+CELL+LUNG+CANCER |
2 | BRAIN METASTASES | 1689 | 65% | 3% | 1597 | Search BRAIN+METASTASES | Search BRAIN+METASTASES |
3 | LUNG CANCER | 1186 | 24% | 9% | 4284 | Search LUNG+CANCER | Search LUNG+CANCER |
4 | CIRCULATING TUMOR CELLS | 537 | 67% | 1% | 488 | Search CIRCULATING+TUMOR+CELLS | Search CIRCULATING+TUMOR+CELLS |
5 | SMALL CELL LUNG CANCER | 536 | 46% | 2% | 882 | Search SMALL+CELL+LUNG+CANCER | Search SMALL+CELL+LUNG+CANCER |
6 | GEFITINIB | 534 | 52% | 2% | 735 | Search GEFITINIB | Search GEFITINIB |
7 | XRCC1 | 468 | 76% | 1% | 324 | Search XRCC1 | Search XRCC1 |
8 | ERLOTINIB | 411 | 48% | 1% | 630 | Search ERLOTINIB | Search ERLOTINIB |
9 | NSCLC | 366 | 33% | 2% | 919 | Search NSCLC | Search NSCLC |
10 | ERCC1 | 334 | 71% | 1% | 273 | Search ERCC1 | Search ERCC1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GEFITINIB | 1268 | 49% | 4% | 1906 |
2 | BRONCHOGENIC CARCINOMA | 912 | 55% | 2% | 1145 |
3 | ERLOTINIB | 900 | 56% | 2% | 1101 |
4 | CEREBRAL METASTASES | 802 | 79% | 1% | 517 |
5 | EGFR MUTATIONS | 731 | 68% | 1% | 637 |
6 | EML4 ALK FUSION GENE | 602 | 87% | 1% | 297 |
7 | CELL LUNG CANCER | 483 | 15% | 6% | 3011 |
8 | VINORELBINE PLUS CISPLATIN | 477 | 71% | 1% | 386 |
9 | SINGLE METASTASES | 471 | 87% | 0% | 232 |
10 | LIMITED RESECTION | 457 | 83% | 1% | 258 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LUNG CANCER | 1178 | 46% | 4% | 1892 |
2 | JOURNAL OF THORACIC ONCOLOGY | 734 | 48% | 2% | 1124 |
3 | CLINICAL LUNG CANCER | 222 | 50% | 1% | 324 |
4 | SEMINARS IN ONCOLOGY | 66 | 11% | 1% | 564 |
5 | THORACIC CANCER | 64 | 37% | 0% | 139 |
6 | JOURNAL OF THORACIC DISEASE | 62 | 24% | 0% | 222 |
7 | THORACIC SURGERY CLINICS | 37 | 35% | 0% | 85 |
8 | REVUE DE PNEUMOLOGIE CLINIQUE | 14 | 16% | 0% | 80 |
9 | JOURNAL OF THORACIC IMAGING | 12 | 10% | 0% | 111 |
10 | TARGETED ONCOLOGY | 5 | 12% | 0% | 38 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma | 2011 | 955 | 400 | 84% |
Second and third-generation epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer | 2015 | 6 | 45 | 100% |
Benefits and Harms of CT Screening for Lung Cancer A Systematic Review | 2012 | 233 | 58 | 84% |
Acquired resistance to TKIs in solid tumours: learning from lung cancer | 2014 | 36 | 68 | 96% |
Epidermal growth factor receptor mutations in lung cancer | 2007 | 958 | 165 | 55% |
Circulating Tumor Cells: Liquid Biopsy of Cancer | 2013 | 101 | 37 | 84% |
Circulating tumor cells: approaches to isolation and characterization | 2011 | 269 | 101 | 76% |
Screening for Lung Cancer With Low-Dose Computed Tomography: A Systematic Review to Update the U. S. Preventive Services Task Force Recommendation | 2013 | 92 | 90 | 86% |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Resistant Disease | 2013 | 87 | 94 | 89% |
Drug therapy: EGFR antagonists in cancer treatment | 2008 | 761 | 94 | 49% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | THORAC SURG | 748 | 20% | 7.1% | 3319 |
2 | THORAC ONCOL | 311 | 38% | 1.4% | 644 |
3 | GUANGDONG LUNG CANC | 99 | 70% | 0.2% | 82 |
4 | THORAC ONCOL SERV | 96 | 60% | 0.2% | 104 |
5 | GEN THORAC SURG | 86 | 21% | 0.8% | 371 |
6 | LOWE THORAC ONCOL | 86 | 61% | 0.2% | 91 |
7 | THORAC ONCOL UNIT | 78 | 65% | 0.2% | 75 |
8 | MULTIDISCIPLINARY THORAC ONCOL PROGRAM | 68 | 65% | 0.1% | 64 |
9 | THORAXKLIN | 46 | 34% | 0.2% | 111 |
10 | THORAC ONCOL PROGRAM | 45 | 42% | 0.2% | 83 |
Related classes at same level (level 3) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000003207 | MESOTHELIOMA//ASBESTOS//PLEURODESIS |
2 | 0.0000003150 | DIHYDROPYRIMIDINE DEHYDROGENASE//5 FLUOROURACIL//THYMIDINE PHOSPHORYLASE |
3 | 0.0000002206 | MEDICAL PHYSICS//RADIAT ONCOL//PHYSICS IN MEDICINE AND BIOLOGY |
4 | 0.0000002116 | BREAST CANCER//BREAST//BRCA1 |
5 | 0.0000001859 | NUCL MED//RADIOIMMUNOTHERAPY//JOURNAL OF NUCLEAR MEDICINE |
6 | 0.0000001852 | CONGENITAL DIAPHRAGMATIC HERNIA//GASTROSCHISIS//CONGENITAL CYSTIC ADENOMATOID MALFORMATION |
7 | 0.0000001774 | PITUITARY ADENOMA//CRANIOPHARYNGIOMA//ACROMEGALY |
8 | 0.0000001609 | HER 2//TRASTUZUMAB//CHRONIC MYELOID LEUKEMIA |
9 | 0.0000001492 | MEDICAL PHYSICS//RADIATION DOSE//DIGITAL MAMMOGRAMS |
10 | 0.0000001471 | HEPATOCELLULAR CARCINOMA//CONTRAST MEDIA//LIVER RESECTION |